Farmington, Connecticut-based Evariant, which offers healthcare providers a platform to analyze data, execute marketing campaigns, and improve patient engagement, has received an undisclosed investment from McKesson Ventures and Salesforce Ventures. The additional investment extends the $42.3 million round the company announced in November, which included investors Health Enterprise Partners, Lightspeed Venture Partners, and Goldman, Sachs & Co.
“This additional investment positions Evariant to continue to help health systems and hospitals grow revenue through strategic patient acquisition and physician alignment,” Evariant Co-Founder and CEO William Moschella said in a statement. “By tapping big data and analytics, healthcare leaders can turn clinical data into meaningful insights that drive proactive health, and increased profitability.”
Evariant's platform, which is built on Salesforce's CRM platform, offers care providers a place to track patient demographics, claims, clinical data, and financial information. eVariant also provides customers with a call center, secure messaging, and texting for patient engagement.
Evariant arms health systems with the tools needed to take complex internal and external data streams and generate marketing, financial, clinical, and operational insights so that they can deliver a more patient-centric approach to care,” Tom Rodgers, SVP and managing director, of McKesson Ventures said in a statement. “By optimizing the data available, health systems gain the ability to identify, attract and engage the right patients and the right physicians which is becoming key as health systems shift their weight from traditional fee-for-service and establish their footing in a value-based world.”
Evariant now counts 600 hospitals among its customers, including six of the top 10 health systems in the United States. The company's customers include University of Chicago Medicine, Scripps Health, Orlando Health, Dignity Health, and Indiana University Health.